PolyPid Ltd. PYPD
6.55 USD -0.01 (-0.15%)
Regular-session close
6.50 -0.05 -0.76%
After hours · Nov 19, 6:15 PM ET
6.40 Day range 7.25
3.50 52-week range 7.25
- YTD
- +50.92%
- 1 year
- +81.94%
News
benzinga.com HC Wainwright & Co. Reiterates Buy on PolyPid, Maintains $13 Price Target HC Wainwright & Co. analyst Brandon Folkes reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $13 price target.
benzinga.com PolyPid Q3 2026 Earnings Call Transcript PolyPid (NASDAQ:PYPD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com PolyPid Q3 EPS $(0.24) Misses $0.06 Estimate PolyPid (NASDAQ:PYPD) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $0.06 by 500 percent. This is a 35.14 percent increase over losses of $(0.37) per…
benzinga.com This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).
benzinga.com This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
benzinga.com This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.
benzinga.com This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated Buy coverage on DRIO ($6), WATT ($15), PPL ($41), DNTH ($113); PYPD rated Outperform with a $10 target.benzinga.com Oppenheimer Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $10 Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.
